Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568203
                    [Title] => Novartis drug offers unique mode of action
                    [Summary] => 
The novel drug aliskiren, through its unique mode of action, can address the limitations of currently available anti-hypertensive drugs, according to experts.
                    [DatePublished] => 2010-04-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 568073
                    [Title] => Novartis gives more Filipino patients access to innovative hypertension treatment
                    [Summary] => 
Research-based Swiss healthcare company Novartis announced the inclusion of its novel anti-hypertension drug, aliskiren, in the company’s patient compliance program to give more Filipino patients access to the innovative treatment.
                    [DatePublished] => 2010-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

RENIN

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 568203
                    [Title] => Novartis drug offers unique mode of action
                    [Summary] => 
The novel drug aliskiren, through its unique mode of action, can address the limitations of currently available anti-hypertensive drugs, according to experts.
                    [DatePublished] => 2010-04-22 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 568073
                    [Title] => Novartis gives more Filipino patients access to innovative hypertension treatment
                    [Summary] => 
Research-based Swiss healthcare company Novartis announced the inclusion of its novel anti-hypertension drug, aliskiren, in the company’s patient compliance program to give more Filipino patients access to the innovative treatment.
                    [DatePublished] => 2010-04-21 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => 
                )

        )

)

abtest

Novartis drug offers unique mode of action

April 22, 2010 - 12:00am

The novel drug aliskiren, through its unique mode of action, can address the limitations of currently available anti-hypertensive drugs, according to experts.

Science and Environment

Novartis gives more Filipino patients access to innovative hypertension treatment

April 21, 2010 - 12:00am

Research-based Swiss healthcare company Novartis announced the inclusion of its novel anti-hypertension drug, aliskiren, in the company’s patient compliance program to give more Filipino patients access to...

Headlines